The newest treatment for asthma is Tezepelumab (Tezspire®), a biologic medication approved by the FDA in 2021.
Understanding Tezepelumab
Tezepelumab is designed to treat moderate to severe asthma by targeting and reducing inflammation in the airways. Unlike some other asthma treatments, it does not target specific inflammatory pathways, but instead works by blocking a protein called TSLP, which is released by the airway lining and is thought to promote airway inflammation.
How is Tezepelumab Administered?
- Tezepelumab is administered via an injection.
- A healthcare provider will give the injection every four weeks.
Key Facts About Tezepelumab:
| Feature | Details |
|---|---|
| Medication | Tezepelumab (Tezspire®) |
| Type | Biologic |
| Approval | FDA approved in 2021 |
| Target | Moderate to severe asthma |
| Mechanism | Reduces inflammation by targeting TSLP |
| Administration | Injection every four weeks, administered by a provider |
Benefits of Tezepelumab
- Helps reduce inflammation in the lungs.
- May lead to fewer asthma attacks.
- Can improve breathing and overall lung function.
By understanding how Tezepelumab works and its administration method, individuals with moderate to severe asthma can have a new option to manage their symptoms. It's important to consult with a healthcare professional to determine if this treatment is right for you.
